KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other Non-Current Liabilities (2019 - 2026)

GoodRx Holdings' Other Non-Current Liabilities history spans 7 years, with the latest figure at $8.7 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 29.4% to $8.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.7 million, a 29.4% increase, with the full-year FY2025 number at $8.7 million, up 29.4% from a year prior.
  • Other Non-Current Liabilities hit $8.7 million in Q4 2025 for GoodRx Holdings, up from $7.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for GDRX hit a ceiling of $9.6 million in Q2 2023 and a floor of $4.7 million in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $7.4 million across 5 years, with a median of $7.6 million in 2022.
  • Biggest five-year swings in Other Non-Current Liabilities: fell 25.09% in 2022 and later soared 70.04% in 2023.
  • Tracing GDRX's Other Non-Current Liabilities over 5 years: stood at $5.4 million in 2021, then surged by 40.41% to $7.6 million in 2022, then grew by 8.2% to $8.2 million in 2023, then dropped by 17.39% to $6.8 million in 2024, then grew by 29.4% to $8.7 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for GDRX at $8.7 million in Q4 2025, $7.6 million in Q3 2025, and $7.0 million in Q2 2025.